Cardiovascular Imaging Registry of Canada

NCT04367220 · tracked via the Priya Life Science Canada tracker

Sponsor

University of Calgary

Phase

Observational

Started

2014-08

Last updated

2024-03-12

Condition(s) studied

Cardiovascular Diseases

Investigational drug(s) / intervention(s)

Diagnostic testing performed as per routine care

Study summary

A multi-site, multi-modality prospective observational clinical outcomes study focussed on the development of phenotype-dirven risk prediction modelling in patients with known or suspected cardiovascular disease.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * All patients referred for hospital-based cardiac imaging services Exclusion Criteria: * Failure or provide informed consent

Primary outcome measure(s)

Major adverse cardiovascular outcomes (MACE) — 2024
Composite of all-cause death, heart failure admission, myocardial infarction, heart transplantation or LVAD, Stroke or TIA
Malignant arrhythmic events — 2024
Composite of sudden cardiac death or appropriate ICD shock
Heart failure events — 2024
Composite of heart failure admission, death or need for transplantation / LVAD
Atrial arrhythmic events — 2024
Occurrence of atrial fibrillation / atrial flutter (documented by 12-lead ECG or Holter monitor)
All-cause mortality — 2024
Death based on Vital Statistics Alberta and In-hospital coded death

Trial sites (4)

Facility	City	Region	Status
Foothills Medical Centre	Calgary	Alberta	Recruiting
South Health Campus	Calgary	Alberta	Recruiting
Peter Lougheed Hospital	Calgary	Alberta	Recruiting
Rockyview Hospital	Calgary	Alberta	Recruiting

More University of Calgary trials in Canada

A Novel Iron-Based Supplement for Athletes Aged 18-25: Phase II Active, not recruiting

Spinal Cord Stimulation for Blood Pressure Control in Hypertension Starting soon

CAlgary SAlt for POTS Recruiting

Analgesic Efficacy of Surgeon-administered Transversus Abdominis Plane Blocks for Caesarean Section. Recruiting

Transauricular Vagus Nerve Stimulation for Chronic Whiplash Associated Disorders Recruiting

Other trials for the same condition

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation Active, not recruiting

IAMABLE: Implementation and Evaluation of an App for Evidence-Based Self-Management Rehabilitation Strategies Recruiting

Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes Recruiting

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease Recruiting

Using Big Data to Conduct Innovative Cardiovascular Clinical Trials Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04367220 on ClinicalTrials.gov ↗ ← All trials in Canada